TOKYO – China Resources Pharmaceutical Group (CR Pharma) launched an IPO roadshow in Hong Kong as it looks to raise as much as $2 billion in capital. The company is a part of China Resources Holdings, a state-owned Chinese conglomerate with a wide distribution network across the world's most populous nation.